The RDIF says that the pharmaceutical lobby is hindering the promotion of Sputnik V in the EU

"The vaccine (" Sputnik V ". -

) may be attacked by the Western pharmaceutical lobby," the RDIF commented on the situation to URA.RU.

The fund noted that they are working closely with the European Medicines Agency in order to promote the drug in Europe.

At the same time, the RDIF called false and inaccurate information published by Reuters with reference to sources that Sputnik V is not recognized in the EU due to a lack of data on clinical trials.

Earlier it was reported that RDIF has agreed to cooperate with the world's largest vaccine manufacturer.

It also became known that Sputnik V has confirmed its effectiveness against new strains of coronavirus.